Debing Xiang

1.9k total citations · 1 hit paper
32 papers, 1.5k citations indexed

About

Debing Xiang is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Debing Xiang has authored 32 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Oncology and 5 papers in Immunology. Recurrent topics in Debing Xiang's work include RNA modifications and cancer (6 papers), DNA Repair Mechanisms (4 papers) and Cancer Cells and Metastasis (3 papers). Debing Xiang is often cited by papers focused on RNA modifications and cancer (6 papers), DNA Repair Mechanisms (4 papers) and Cancer Cells and Metastasis (3 papers). Debing Xiang collaborates with scholars based in China, United States and India. Debing Xiang's co-authors include Zhaoyang Zhong, Qing Ji, Xinbao Hao, Min Zhang, Ling Li, Jeffrey DeSano, Daiming Fan, Eric R. Fearon, Theodore S. Lawrence and Wenhua Tang and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Debing Xiang

30 papers receiving 1.5k citations

Hit Papers

MicroRNA miR-34 Inhibits Human Pancreatic Cancer Tumor-In... 2009 2026 2014 2020 2009 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Debing Xiang China 18 1.1k 524 362 147 108 32 1.5k
Peng Bai China 24 972 0.9× 380 0.7× 192 0.5× 84 0.6× 55 0.5× 69 1.5k
Călin Ionescu Romania 14 814 0.7× 447 0.9× 265 0.7× 114 0.8× 88 0.8× 20 1.3k
Dixian Luo China 25 1.2k 1.1× 654 1.2× 190 0.5× 106 0.7× 105 1.0× 81 1.9k
Roxana Cojocneanu Romania 25 1.1k 1.0× 858 1.6× 179 0.5× 73 0.5× 96 0.9× 57 1.6k
Haiping Jiang China 18 562 0.5× 226 0.4× 385 1.1× 191 1.3× 92 0.9× 45 1.2k
Minami Kumazaki Japan 26 1.5k 1.4× 1.2k 2.4× 185 0.5× 221 1.5× 55 0.5× 33 1.9k
Ling‐Wen Ding Singapore 29 1.6k 1.5× 541 1.0× 506 1.4× 260 1.8× 143 1.3× 65 2.4k
Ranjini K. Sundaram United States 20 557 0.5× 165 0.3× 369 1.0× 274 1.9× 64 0.6× 45 1.4k
D. Lynn Kirkpatrick United States 18 1.4k 1.2× 436 0.8× 282 0.8× 126 0.9× 54 0.5× 34 1.8k
Mariko Shimamura Japan 24 826 0.7× 251 0.5× 353 1.0× 192 1.3× 79 0.7× 58 1.5k

Countries citing papers authored by Debing Xiang

Since Specialization
Citations

This map shows the geographic impact of Debing Xiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debing Xiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debing Xiang more than expected).

Fields of papers citing papers by Debing Xiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debing Xiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debing Xiang. The network helps show where Debing Xiang may publish in the future.

Co-authorship network of co-authors of Debing Xiang

This figure shows the co-authorship network connecting the top 25 collaborators of Debing Xiang. A scholar is included among the top collaborators of Debing Xiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debing Xiang. Debing Xiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jia, Qingzhu, Gang Chen, Debing Xiang, et al.. (2022). 568P First-in-human anti-ALPP CAR-T cell immunotherapy for ovarian and endometrial cancer. Annals of Oncology. 33. S807–S807. 4 indexed citations
3.
Huang, Lin, et al.. (2021). TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways. Aging. 13(9). 13225–13238. 18 indexed citations
4.
Li, Bo, et al.. (2020). <p>Efficacy and Safety of Iodine-125 Brachytherapy in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma</p>. OncoTargets and Therapy. Volume 13. 9657–9666. 2 indexed citations
6.
Li, Bo, et al.. (2018). Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly. OncoTargets and Therapy. Volume 11. 6617–6624. 20 indexed citations
7.
Ding, Zhenfeng, Shuang Liu, Xianwei Wang, et al.. (2014). LOX-1, mtDNA damage, and NLRP3 inflammasome activation in macrophages: implications in atherogenesis. Cardiovascular Research. 103(4). 619–628. 115 indexed citations
8.
Tang, Xu-Dong, et al.. (2012). TNM Stages and Prognostic Features of Colorectal and Mucinous Adenocarcinoma Patients: a Meta Analysis. Asian Pacific Journal of Cancer Prevention. 13(7). 3427–3430. 18 indexed citations
9.
Zhang, Zhimin, Xueqin Yang, Dong Wang, et al.. (2011). Nm23-H1 Protein Binds to APE1 at AP Sites and Stimulates AP Endonuclease Activity Following Ionizing Radiation of the Human Lung Cancer A549 Cells. Cell Biochemistry and Biophysics. 61(3). 561–572. 14 indexed citations
10.
Li, Mengxia, Debing Xiang, Yi Qing, et al.. (2010). Elevated Expression of APE1/Ref-1 and its Regulation on IL-6 and IL-8 in Bone Marrow Stromal Cells of Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 10(5). 385–393. 26 indexed citations
11.
Li, Mengxia, Zhaoyang Zhong, Debing Xiang, et al.. (2010). Identification and Characterization of Mitochondrial Targeting Sequence of Human Apurinic/Apyrimidinic Endonuclease 1. Journal of Biological Chemistry. 285(20). 14871–14881. 78 indexed citations
12.
Qing, Yi, Xueqin Yang, Zhaoyang Zhong, et al.. (2010). Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays. BMC Cancer. 10(1). 71–71. 25 indexed citations
13.
Xiang, Debing, et al.. (2009). Effects of caffeic acid phenethyl ester on the colorectal cancer via the β-catenin pathway.. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 8(4). 294–297. 1 indexed citations
14.
Zhang, Qinhong, et al.. (2009). Expression of DNA repair gene apurinic/apyrimidinic endonuclease 1 and its correlation with the expression of mutant p53 in hepatocellular carcinoma. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 8(6). 453–456. 1 indexed citations
15.
He, Yujun, Zhirong Mou, Wanlin Li, et al.. (2009). Identification of IMPDH2 as a tumor-associated antigen in colorectal cancer using immunoproteomics analysis. International Journal of Colorectal Disease. 24(11). 1271–1279. 41 indexed citations
17.
18.
Zhong, Zhaoyang, Mengxia Li, Debing Xiang, et al.. (2008). Signal amplification of electrochemical immunosensor for the detection of human serum IgG using double-codified nanosilica particles as labels. Biosensors and Bioelectronics. 24(7). 2246–2249. 64 indexed citations
19.
Zhong, Zhaoyang, et al.. (2007). Vector‐based Ape1 small interfering RNA enhances the sensitivity of human osteosarcoma cells to endostatin in vivo. Cancer Science. 98(12). 1993–2001. 34 indexed citations
20.
He, Yujun, Yuzhang Wu, Zhirong Mou, et al.. (2007). Proteomics‐based identification of HSP60 as a tumor‐associated antigen in colorectal cancer. PROTEOMICS - CLINICAL APPLICATIONS. 1(3). 336–342. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026